Dysregulation of the mTOR pathway in p53-deficient mice

Leontieva, Olga V.; Novototskaya, Liliya R.; Paszkiewicz, Geraldine M.; Komarova, Elena A.; Gudkov, Andrei V.; Blagosklonny, Mikhail V.
December 2013
Cancer Biology & Therapy;Dec2013, Vol. 14 Issue 12, p1
Academic Journal
No abstract available.


Related Articles

  • Dysregulation of mTOR Signaling in Neuropsychiatric Disorders: Therapeutic Implications. Sawicka, Kirsty; Zukin, R Suzanne // Neuropsychopharmacology;Jan2012, Vol. 37 Issue 1, p305 

    The article focuses on the therapeutic implications of dysregulation of PI3K-mammalian target of rapamycin (mTOR) signaling in autism spectrum disorders (ASDs). It notes that mTOR pathway are essential to synaptogenesis and are present at synapses and dysregulation of mTOR is linked to elevated...

  • Mapping the Spatio-Temporal Pattern of the Mammalian Target of Rapamycin (mTOR) Activation in Temporal Lobe Epilepsy. Long-Ze Sha; Xiao-Liang Xing; Dan Zhang; Yuan Yao; Wan-Chen Dou; Li-Ri Jin; Li-Wen Wu; Qi Xu // PLoS ONE;Jun2012, Vol. 7 Issue 6, p1 

    Growing evidence from rodent models of temporal lobe epilepsy (TLE) indicates that dysregulation of the mammalian target of rapamycin (mTOR) pathway is involved in seizures and epileptogenesis. However, the role of the mTOR pathway in the epileptogenic process remains poorly understood. Here, we...

  • 哺乳动物雷帕霉素靶蛋白信号通路上的 miRNA 调控. 张瑾; 金波; 施海明 // Fudan University Journal of Medical Sciences;Sep2016, Vol. 43 Issue 5, p603 

    The mammalian target of rapamycin (mTOR) signal pathway is a key intracellular signal transduction pathway, which plays important roles in cell proliferation, apoptosis, cell cycle and metabolism. Dysregulation of mTOR signalling often occurs in a variety of human malignant diseases, making it a...

  • The Biology Behind mTOR Inhibition in Sarcoma. Xiaolin Wan; Helman, Lee J. // Oncologist;Aug2007, Vol. 12 Issue 8, p1007 

    Dysregulation of the mammalian target of rapamycin (mTOR) pathway has been found in many human tumors and implicated in the promotion of cancer cell growth and survival. Hence, the mTOR pathway is considered an important target for anticancer drug development. Currently, the mTOR inhibitor...

  • Vigabatrin Inhibits Seizures and mTOR Pathway Activation in a Mouse Model of Tuberous Sclerosis Complex. Zhang, Bo; McDaniel, Sharon S.; Rensing, Nicholas R.; Wong, Michael // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Epilepsy is a common neurological disorder and cause of significant morbidity and mortality. Although antiseizure medication is the first-line treatment for epilepsy, currently available medications are ineffective in a significant percentage of patients and have not clearly been demonstrated to...

  • High prevalence of mTOR complex activity can be targeted using Torin2 in papillary thyroid carcinoma. Ahmed, Maqbool; Hussain, Azhar R.; Bavi, Prashant; Ahmed, Saeeda O.; AlSobhi, Saif S.; Al-Dayel, Fouad; Uddin, Shahab; Al-Kuraya, Khawla S. // Carcinogenesis;Jul2014, Vol. 35 Issue 7, p1 

    The mammalian target of rapamycin (mTOR) signaling cascade is a key regulatory pathway controlling initiation of messenger RNA in mammalian cells. Although dysregulation of mTOR signaling has been reported earlier in cancers, there is paucity of data about mTOR expression in papillary thyroid...

  • mTOR-mediated hyperphosphorylation of tau in the hippocampus is involved in cognitive deficits in streptozotocin-induced diabetic mice. Wang, Shan; Zhou, Shan-lei; Min, Fang-yuan; Ma, Jin-ju; Shi, Xia-jie; Bereczki, Erika; Wu, Jing // Metabolic Brain Disease;Sep2014, Vol. 29 Issue 3, p729 

    Abnormal levels of mammalian target of rapamycin (mTOR) signaling have been recently implicated in the pathophysiology of neurodegenerative diseases, such as Alzheimer's disease (AD). However, the implication of mTOR in diabetes mellitus (DM)-related cognitive dysfunction still remains unknown....

  • Targeting the mTOR-DEPTOR Pathway by CRL E3 Ubiquitin Ligases: Therapeutic Application. Yongchao Zhao; Yi Sun // Neoplasia;May2012, Vol. 14 Issue 5, p360 

    The mammalian target of rapamycin (mTOR), an evolutionarily conserved serine/threonine protein kinase, integrates both intracellular and extracellular signals and serves as a central regulator of cell metabolism, growth, proliferation, survival, and autophagy. The mTOR pathway is frequently...

  • Dysregulation of the TSC-mTOR pathway in human disease. Inoki, Ken; Corradetti, Michael N.; Guan, Kun-Liang // Nature Genetics;Jan2005, Vol. 37 Issue 1, p19 

    The mammalian target of rapamycin (mTOR) has a central role in the regulation of cell growth. mTOR receives input from multiple signaling pathways, including growth factors and nutrients, to stimulate protein synthesis by phosphorylating key translation regulators such as ribosomal S6 kinase and...

  • Chemical Inhibitors and microRNAs (miRNA) Targeting the Mammalian Target of Rapamycin (mTOR) Pathway: Potential for Novel Anticancer Therapeutics. AlQurashi, Naif; Hashimi, Saeed M.; Wei, Ming Q. // International Journal of Molecular Sciences;Feb2013, Vol. 14 Issue 2, p3874 

    The mammalian target of rapamycin (mTOR) is a critical regulator of many fundamental features in response to upstream cellular signals, such as growth factors, energy, stress and nutrients, controlling cell growth, proliferation and metabolism through two complexes, mTORC1 and mTORC2....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics